Category: Biotech
US, UK, and Canada Present 10-point Best Practices on Medical AI
With artificial intelligence gaining sway in numerous industries, the US Food and Drug...
Read More
PharmaCyte Biotech Upbeat With $70 Million In Offerings
Biotech company PharmaCyte (NASDAQ: PMCB) is having an upbeat run resource-wise. This after it...
Read More
Rosa Hip Completes Zimmer Biomet’s Surgical Robotics Suite
Zimmer Bioment’s Rosa Hip medical robotics system has been given the go-signal by the US...
Read More
Marinus Anti-Epileptic Drug Enters Third Phase of Clinical Trials
Ganaxolone, an experimental treatment currently being developed by Marinus Pharmaceuticals is set...
Read More
Pharma faces an uphill battle in clinical trial diversity
The issue of representation has been spotlighted in politics, sports, and entertainment. Now the...
Read More
Pharma faces an uphill battle in clinical trial diversity
The issue of representation has been spotlighted in politics, sports, and entertainment. Now the...
Read More
BioNTech rallies 16% after boosting COVID-19 vaccine sales forecast
An increase of about 16% in BioNTech shares was recorded last Monday after the company documented...
Read More
Biotech Company Illumina Posts Substantial Growth in Q2-2021
Diagnostic biotech developer Illumina’s growth in the second quarter of the year bucked...
Read More
Illumina Under Fire in Europe
American biotech innovator Illumina can’t seem to escape from its antitrust woes. It is...
Read More
Kriya Therapeutics lands $100M funding for gene therapy
Gene therapy is making a change of focus from rare diseases to mainstream chronic conditions, and...
Read More
Allied Market Research: Recent Developments Fueling Growth of Global Biotech Market
The most recent biotech industry forecast for the period covering 2021 to 2028 is upbeat. Yet...
Read More
Anavex’s Parkinson’s Disease Drug Reportedly Improves Cognitive Assessment and Motor Responses
Anavex reported the latest development in their neuro drug, stating that the second clinical trial...
Read More
